Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 843-851

  Kanai, Motoshi ^a   Hamada, Jun Ichi ^a   Takada, Minoru ^a   Asano, Toshimichi ^a   Murakawa, Katsuhiko ^a   Takahashi, Yoko ^a   Murai, Taichi ^a   Tada, Mitsuhiro ^a   Miyamoto, Masaki ^a   Kondo, Satoshi ^a   Moriuchi, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Colorectal carcinoma; Hepatocellular carcinoma; HOX; Metastasis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HOX GENE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; TRANSCRIPTION FACTORS;

EID: 77349123961     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000706     Document Type: Article

References (40)

1. Gehring WJ and Hiromi Y: Homeotic genes and the homeobox. Annu Rev Genet 20: 147-173, 1986.
2. Levine M and Hoey T: Homeobox proteins as sequence-specific transcription factors. Cell 55: 537-540, 1988.
3. Ruddle FH, Bartels JL, Bentley KL, Kappen C, Murtha MT and Pendleton JW: Evolution of Hox genes. Annu Rev Genet 28: 423-442, 1994.
4. McGinnis W and Krumlauf R: Homeobox genes and axial patterning. Cell 68: 283-302, 1992.
5. Takahashi Y, Hamada J, Murakawa K, et al: Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res 293: 144-153, 2004.
6. Yahagi N, Kosaki R, Ito T, et al: Position-specific expression of Hox genes along the gastrointestinal tract. Congenit Anom (Kyoto) 44: 18-26, 2004.
7. Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, Morikawa T, Kondo S and Moriuchi T: Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep 15: 797-802, 2006.
8. Makiyama K, Hamada J, Takada M, et al: Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep 13: 673-679, 2005.
9. Maeda K, Hamada J, Takahashi Y, et al: Altered expressions of HOX genes in human cutaneous malignant melanoma. Int J Cancer 114: 436-441, 2005.
10. Hassan NM, Hamada J, Murai T, et al: Aberrant expression of HOX genes in oral dysplasia and squamous cell carcinoma tissues. Oncol Res 16: 217-224, 2006.
11. Takahashi O, Hamada J, Abe M, et al: Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncol Rep 17: 753-760, 2007.
12. Cillo C, Barba P, Freschi G, Bucciarelli G, Magli MC and Boncinelli E: HOX gene expression in normal and neoplastic human kidney. Int J Cancer 51: 892-897, 1992.
13. Miller GJ, Miller HL, van Bokhoven A, et al: Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 63: 5879-5888, 2003.
14. De Vita G, Barba P, Odartchenko N, et al: Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 29A: 887-893, 1993.
15. López R, Garrido E, Vázquez G, et al: A subgroup of HOX Abd-B gene is differentially expressed in cervical cancer. Int J Gynecol Cancer 16: 1289-1296, 2006.
16. Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO and Lobie PE: Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 278: 7580-7590, 2003.
17. Zhai Y, Kuick R, Nan B, et al: Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 67: 10163-10172, 2007.
18. Okuda H, Toyota M, Ishida W, et al: Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma. Oncogene 25: 1733-1742, 2006.
19. Yamashita T, Tazawa S, Yawei Z, et al: Suppression of invasive characteristics by antisense introduction of overexpressed HOX genes in ovarian cancer cells. Int J Oncol 28: 931-938, 2006.
20. Hamada J, Omatsu T, Okada F, et al: Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasisrelated genes in human lung cancer cells. Int J Cancer 93: 516-525, 2001.
21. Miyazaki YJ, Hamada J, Tada M, et al: HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells. Oncogene 21: 798-808, 2002.
22. Ohta H, Hamada J, Tada M, et al: HOXD3-overexpression increases integrin alpha v beta 3 expression and deprives Ecadherin while it enhances cell motility in A549 cells. Clin Exp Metastasis 23: 381-390, 2006.
23. Sadler TW: Langman's medical embryology; Leland J: Original illustrations; Sadler-Redmond SL:Computer illustrations; Sulik KK and Burgoon J: Scanning electron micrographs; Chescheir N and Imseis H: Ultrasound images. 9th edition. Lippincott Williams & Wilkins, Philadelphia, Tokyo, 2004.
24. Glebov OK, Rodriguez LM, Nakahara K, et al: Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 12: 755-762, 2003.
25. Zeltser L, Desplan C and Heintz N: Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development 122: 2475-2484, 1996.
26. Kawazoe Y, Sekimoto T, Araki M, Takagi K, Araki K and Yamamura K: Region-specific gastrointestinal Hox code during murine embryonal gut development. Dev Growth Differ 44: 77-84, 2002.
27. Dollé P, Izpisúa-Belmonte JC, Boncinelli E and Duboule D: The Hox-4.8 gene is localized at the 5' extremity of the Hox-4 complex and is expressed in the most posterior parts of the body during development. Mech Dev 36: 3-13, 1991.
28. Delattre O, Olschwang S, Law DJ, et al: Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 334: 353-356, 1989.
29. Breivik J, Lothe RA, Meling GI, Rognum TO, B.rresen-Dale AL and Gaudernack G: Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74: 664-649, 1997.
30. Hamelin R, Laurent-Puig P, Olschwang S, et al: Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106: 42-48, 1994.
31. Hawkins N, Norrie M, Cheong K, et al: CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122: 1376-1387, 2002.
32. Jass JR, Whitehall VL, Young J and Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 123: 862-876, 2002.
33. Iacopetta B: Are there two sides to colorectal cancer? Int J Cancer 101: 403-408, 2002.
34. Raman V, Martensen SA, Reisman D, et al: Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405: 974-978, 2000.
35. Tricoli JV, Rall LB, Karakousis CP, et al: Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 46: 6169-6173, 1986.
36. Messa C, Russo F, Caruso MG and Di Leo A: EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma. Acta Oncol 37: 285-289, 1998.
37. Whelan JT, Ludwig DL and Bertrand FE: HoxA9 induces insulinlike growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia. Leukemia 22: 1161-1169, 2008.
38. Strathdee G, Holyoake TL, Sim A, et al: Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 13: 5048-5055, 2007.
39. Bagadi SA, Prasad CP, Kaur J, et al: Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients. Life Sci 82: 1288-1292, 2008.
40. Duriseti S, Winnard PT Jr, Mironchik Y, Vesuna F, Raman A and Raman V: HOXA5 regulates hMLH1 expression in breast cancer cells. Neoplasia 8: 250-258, 2006.